During the past decade, MDS Pharma Services conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MDS Pharma Services" #1 sponsor was "GlaxoSmithKline" with 4 trials, followed by "Actavis Inc." with 2 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Global Alliance for TB Drug Development" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MDS Pharma Services" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator and "Halozyme Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MDS Pharma Services" are "Healthy" (8 trials), "Healthy Subjects" (5 trials), "Nausea" (2 trials), "Tuberculosis" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "MDS Pharma Services" in a lesser frequency.

Most popular intervention types in "MDS Pharma Services" are "Drug" (20 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Experimental paracetamol formulation" (3 trials), "Marketed paracetamol" (3 trials), "APD791" (2 trials), "Granisetron" (2 trials) and "Avinza (morphine sulfate sustained-release) capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "MDS Pharma Services" are 19 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "MDS Pharma Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in MDS Pharma Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MDS Pharma Services, 18 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".